Male osteoporosis

Current Opinion in Rheumatology

Volumn 8, Issue 4, 1996, Pages 357-364

  Peris, Pilar ^a   Guañabens, Nuria ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DEVELOPMENT; BONE MASS; GENDER; HUMAN; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE;

EID: 0029738280     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199607000-00014     Document Type: Review

References (96)

1. Cooper C, Campion G, Melton III LJ: Hip fractures in the elderly: a world-wide projection. Osteoporosis Int 1992, 2:285-289.
2. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ III: Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 1992, 7:221-227.
3. Johansson C, Mellström D, Rosengren K, Rundgren A: A community-based population study of vertebral fractures in 85-year-old men and women. Age Ageing 1994, 23:388-392.
4. Scane AC, Sutcliffe AM, Francis RM: Osteoporosis in men. Baillieres Clin Rheumatol 1993, 7:589-601.
5. Scane AC, Sutcliffe AM, Francis RM: The sequelae of vertebral crush fractures in men. Osteoporosis Int 1994, 4:89-92.
6. Francis RM, Peacock M, Marshall DH, Horsman A, Aaron JE: Spinal Osteoporosis in men. Bone Miner 1989, 5:347-357.
7. 3 levels.
8. Kelepouris N, Harper KD, Gannon F, Kaplan FS, Haddad JG: Severe Osteoporosis in men. Ann Intern Med 1995, 123:452-460. This study consists of a case series with an extensive clinical review of male Osteoporosis. Patients with idiopathic Osteoporosis had normal bone formation rates and slightly increased resorption surfaces. Forty-one percent of these patients had fasting hypercalciuria.
9. Khosla S, Lufkin EG, Hodgson SF, Fitzpatrick LA, Melton III LJ: Epidemiology and clinical features of Osteoporosis in young individuals. Bone 1994, 15:551-555.
10. Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CYC: Impaired bone formation in male idiopathic Osteoporosis: further reduction In the presence of concomitant hypercalciuria. Osteoporosis Int 1992, 2:128-134.
11. Perry III HM, Fallon MD, Bergfeld M, Teitelbaum SL, Avioli LV: Osteoporosis in young men: a syndrome of hypercalciuria and accelerated bone turnover. Arch Intern Med 1982, 142:1295-1298.
12. WHO Study Group: Osteoporosis. In Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. WHO Technical report series 843. Geneva: World Health Organization; 1994:2-25.
13. Kanis JA, Melton III JL, Christiansen C, Johnston CC, Khaltaev N: The diagnosis of Osteoporosis. J Bone Miner Res 1994, 9:1137-1141.
14. Gómez C, Diaz JB, Naves ML, Altadill A, Fernández JL, Cannata JB: Diagnóstico densitométrico de osteoporosis [abstract]. Rev Esp Enferm Metab Os 1995, 4(suppl A):S18.
15. Boyce WJ, Wessey MP: Rising incidence of fracture of the proximal femur. Lancet 1985, i:150-151.
16. Peris P, Guañabens N, Parés A, Pons F, Del Rio L, Monegal A, Suris X, Caballeria J, Rodés J, Muñoz-Gómez J: Vertebral fractures and osteopenia in chronic alcoholic patients. Calcif Tissue Int 1995, 57:111-114.
17. Stewart A, Felsenberg D, Kalidis L, Reid DM: Vertebral fractures in men and women: how discriminative are bone mass measurements? Br J Radiol 1995, 68:614-620.
18. Resch A, Scheinder B, Bernecker P, Battmann A, Wergedal J, Willvonseder R, Resch H: Risk of vertebral fractures in men: relationship to mineral density of vertebral body. AJR Am J Roentgenol 1995, 164:1447-1450.
19. Mann T, Oviatt SK, Wilson D, Nelson D, Orwoll ES: Vertebral deformity in men. J Bone Miner Res 1992, 7:1259-1265.
20. Grisso JA, Chiu GY, Maislin G, Steinmann WC, Portale J: Risk factors for hip fractures in men: a preliminary study. J Bone Miner Res 1991, 6:865-868.
21. Lau E, Donnan S, Barker DJP, Cooper C: Physical activity and calcium intake in fracture of the proximal femur in Hong Kong. BMJ 1988, 297:1441-1443.
22. Seeman E: Osteoporosis in men: epidemiology, pathophysiology, and treatment possibilities. Am J Med 1993, 95(suppl 5A):22-28.
23. Kelly PJ, Twomey L, Sambrook PN, Eisman JA: Sex differences in peak adult bone mineral density. J Bone Miner Res 1990, 5:1169-1175.
24. Aaron JE, Makins NB, Sagreiya K: The microanatomy of trabecular bone loss in normal aging men and women. Clin Orthop 1987, 215:260-271.
25. Jouanny P, Guillemin F, Kuntz C, Jeandel C, Pourel J: Environmental and genetic factors affecting bone mass. Arthritis Rheum 1995, 38:61-67.
26. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA: Prediction of bone density from vitamin D receptor alleles. Nature 1994, 367:284-287.
27. Zerwekh JE, Hughes MR, Reed BY, Breslau NA, Heller HJ, Lemke M, Nasonkin I, Pak CYC: Evidence for normal vitamin D receptor messenger ribonucleic acid and genotype in absorptive hypercalciuria. J Clin Endocrinol Metab 1995, 80:2960-2965. The authors analyzed the vitamin D receptor gene in a group of 33 patients with absorptive hypercalciuria and compared the results with those of 36 age-matched control subjects. They did not find differences in the distribution of the vitamin D receptor alleles nor in the coding region of vitamin D receptor messenger RNA in the patient population compared with the control group.
28. Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S: Growth hormone-dependent Insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 1994, 9:915-921.
29. Wright NM, Renault J, Willi S, Veldhuis JD, Pandey JP, Gordon L, Key LL, Bell NH: Greater secretion of growth hormone in black than in white men: possible factor in greater bone mineral density: a clinical research center study. J Clin Endocrinol Metab 1995, 80:2291-2297.
30. Välimäki MJ, Kärkkäinen M, Lamberg-Allardt C, Laitinen K, Alhava E, Heikkinen J, Impivaara O, Mäkelä P, Palmgren J, Seppänen R, Vuori I: Exercise, smoking, and calcium intake during adolescence and early adulthood as determinants of peak bone mass. BMJ 1994, 309:230-235.
31. Welten DC, Kemper HCG, Post GB, Mechelen WV, Twisk J, Lips P, Teule GJ: Weight-bearing activity during youth is a more important factor for peak bone mass than calcium intake. J Bone Miner Res 1994, 9:1089-1096.
32. Wishart JM, Need AG, Horowitz M, Morris HA, Nordin BE: Effect of age on bone density and bone turnover in men. Clin Endocrinol 1995, 42:141-146. Cross-sectional measurement of bone mass and markers of bone turnover in 147 healthy men, concluding that bone loss in men appears to accelorate from age 50 and is associated with decreased bone formation, which may be associated with falling levels of free androgen.
33. Hannan MT, Felson DT, Anderson JL: Bone mineral density in elderly men and women: results from the Framingham Osteoporosis Study. J Bone Miner Res 1992, 7:547-552.
34. Maggio D, Pacifici R, Cherubini A, Aisa MC, Santucci C, Cucinotta D, Senin U: Appendicular cortical bone loss after age 65: sex-dependent event? Calcif Tissue Int 1995, 56:410-414.
35. Felson DT, Zhang Y, Hannan MY, Anderson JJ: Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 1993, 8:567-573.
36. May H, Murphy S, Khaw KT: Age-associated bone loss in men and women and its relationship to weight Age Ageing 1994, 23:235-240.
37. Delichatsios HK, Lane JM, Rivlin RS: Bone histomorphometry in men with spinal osteoporosis. Calcif Tissue Int 1995, 56:359-363. The authors analyzed the effect of age and predisposing risk factors on the pattern of bone turnover in 21 men with spinal osteoporosis (67% with secondary causes) using bone histomorphometric study.
38. Jackson JA, Kleerekoper M, Parfitt AM, Rao DS, Villanueva AR, Frame B: Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab 1987, 65:53-58.
39. Jackson JA, Kleerekoper M: Osteoporosis in men: diagnosis, pathophysiology, and prevention. Medicine 1990, 69:137-152.
40. Philip WJU, Martin JC, Richardson JM, Reid DM, Webster J, Douglas AS: Decreased axial and peripheral bone density in patients taking long-term warfarin. Q J Med 1995, 88:635-640.
41. Laroche M, Moulinier L, Bon E, Cantagrel A, Mazieres B: Renal tubular disorders and arteriopathy of the lower limbs: risk factors for osteoporosis in men? Osteoporosis Int 1994, 4:309-313.
42. Slemenda CW, Christian JC, Reed T, Roister TK, Williams CJ, Johnston CC: Long-term bone loss in men: effects of genetic and environmental factors. Ann Intern Med 1992, 117:286-291.
43. Seeman E, Melton III LJ, O'Fallon WM, Riggs BL: Risk factors for spinal osteoporosis in men. Am J Med 1983, 75:977-983.
44. May H, Murphy S, Khaw KT: Cigarette smoking and bone mineral density in older men. Q J Med 1994, 87:625-630.
45. Need AG, Wishart JM, Scopacasa F, Horowitz M, Morris HA, Nordin BEC: Effect of physical activity on femoral bone density in men. BMJ 1995, 310:1501-1502.
46. Kannus P, Järvinen M, Sievänen H, Oja P, Vuori I: Osteoporosis in men with a history of tibial fracture. J Bone Miner Res 1994, 9:423-429.
47. Kannus P, Järvinen M, Sievänen H, Järvinen TAH, Oja P, Vuori I: Reduced bone mineral density in men with previous femur fracture. J Bone Miner Res 1994, 9:1729-1736.
48. Lukert BP, Raisz LG: Glucocorticoid-induced osteoporosis: pathogenesis and management Ann Intern Med 1990, 112:352-364.
49. Krogsgaard MR, Thamsborg G, Lund B: Changes in bone mass during low dose corticosteroid treatment in patients with polymyalgia rheumatica: a double blind, prospective comparison between prednisolone and deflazacort. Ann Rheum Dis 1996, 55:143-146.
50. Laitinen K, Valimaki M: Alcohol and bone. Calcif Tissue Int 1991, 49(suppl):70S-73S.
51. González-Calvin JL, Garcia-Sánchez A, Bellot V, Muñoz-Torres M, Raya-Alvarez E, Salvatierra-Rios D: Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism. Alcohol Alcoholism 1993, 28:571-579.
52. Peris P, Parés A, Guañabens N, Del Rio L, Pons F, Martinez de Osaba MJ, Monegal A, Caballeria J, Rodés J, Muñoz-Gómez J: Bone mass Improves in alcoholics after 2 years of abstinence. J Bone Miner Res 1994, 9:1607-1612.
53. Crilly RG, Delaquerriére-Richardson L: Current bone mass and body weight changes in alcoholic males. Calcif Tissue Int 1990, 46:169-172.
54. Laitinen K, Välimäki M, Lamberg-Allardt C, Kivisaari L, Lalla M, Kärkkäinen M, Ylikahri R: Deranged vitamin D metabolism but normal bone mineral density in Finnish noncirrhotic male alcoholics. Alcohol Clin Exp Res 1990, 14:551-556.
55. Finkelstein JS, Neer RM, Biller BMK, Crawford JD, Klibanski A: Osteopenia in men with a history of delayed puberty. N Engl J Med 1992, 326:600-604.
56. Stearns EL, MacDonnel JA, Kaufman BJ, Padua R, Lucman TS, Winter JSD, Faiman C: Declining testicular function with age. Am J Med 1974, 57:761-766.
57. Vermeulen A, Kaufman JM: Role of the hypothalamo-pituitary function in the hypoandrogenism of healthy aging. J Clin Endocrinol Metab 1992, 75:704-706.
58. Vanderschueren D, Bouillon R: Androgens and bone. Calcif Tissue Int 1995, 56:341-346. Review on the effect of androgens on bone metabolism, including in vitro evidence of androgen action in bone homeostasis in both experimental and human studies.
59. Murphy S, Khaw KT, Cassidy A, Compston JE: Sex hormones and bone mineral density in elderly men. Bone Miner 1993, 20:133-140.
60. Drinka PJ, Olson J, Bauwens S, Voeks SK, Carlson I, Wilson M: Lack of association between free testosterone and bone density separate from age in elderly males. Calcif Tissue Int 1993, 52:67-69.
61. Bardin CW, Swerdloff RS, Santen RJ: Androgens: risks and benefits. J Clin Endocrinol Metab 1991, 73:4-7.
62. Collinson MP, Tyrrell CJ, Hutton C: Osteoporosis occurring in two patients receiving LHRH analogs for carcinoma of the prostate. Calcif Tissue Int 1994, 54:327-328.
63. Eriksson S, Eriksson A, Stege R, Carlström K: Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens. Calcif Tissue Int 1995, 57:97-99. The authors analyzed the effect of therapy for prostatic cancer in 27 patients (11 with orchidectomy and 16 with estrogens) on BMD after 1 year of therapy. Estrogen-treated patients did not show variations in BMD, whereas patients who underwent orchidectomy developed bone loss.
64. Francis RM, Peacock M, Aaron JE, Selby PL, Taylor GA, Thompson J, Marshall DH, Horsman A: Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone 1986, 7:261-268.
65. Baran DT, Bergfeld MA, Teitelbaum SL, Avioli LV: Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male. Calcif Tissue Int 1978, 26:103-106.
66. 3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 1982, 72:25-32.
67. Pietschmann F, Breslau NA, Pak CYC: Reduced vertebral bone density in hypercalcluric nephrolithiasis. J Bone Miner Res 1992, 7:1383-1388.
68. Lemman J: Pathogenesis of idiopathic hypercalciuria and nephrolithiasis. In Disorders of Bone and Mineral Metabolism. Edited by Coe FL, Favus MJ. New York: Raven Press; 1992:685-706.
69. Bianchi G, Vezzoli G, Cusi D, Cova T, Elli A, Soldati L, Tripodi G, Surian M, Ottaviano E, Rigatti P, Ortolani S: Abnormal red-cell calcium pump in patients with idiopathic hypercalciuria. N Engl J Med 1988, 319:897-901.
70. Villareal DT, Civitelli R, Chines A, Avioli L: Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. J Clin Endocrinol Metab 1991, 72:628-634.
71. Khaw KT, Sneyd MJ, Compston J: Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. BMJ 1992, 305:273-277.
72. Ljunghall S, Johansson AG, Burman P, Kämpe O, Lindh E, Karlsson FA: Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic Osteoporosis. J Intern Med 1992, 232:59-64.
73. Reed BY, Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CYC: Serum IGF-1 is low and correlated with osteoblastic surface in idiopathic Osteoporosis. J Bone Miner Res 1995, 10:1218-1224.
74. Johansson AG, Lindh E, Blum WF, Eriksen EF, Langdahl B, Lindahl A, Ljunghall S: Idiopathic Osteoporosis in men: evidence for reduced serum levels of the growth hormone-dependent IGF binding protein and a negative bone balance at the level of individual remodeling units [abstract]. Bone 1995, 16(suppl):102.
75. Pacifici R, Rifas L, Teitelbaum S, Slatopolsky E, McCracken R, Bergfeld M, Lee W, Avioli LV, Peck WA: Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic Osteoporosis. Proc Natl Acad Sci USA 1987, 84:4616-4620.
76. Ahmed SR, Boucher AE, Manni A, Santen RJ, Bartholomew M, Demers LM: Transdermal testosterone therapy in the treatment of male hypogonadism. J Clin Endocrinol 1988, 66:546-551.
77. Bertelloni S, Baroncelli GI, Battini R, Perri G, Saggese G: Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty. J Bone Miner Res 1995, 10:1488-1495.
78. Tenover JS: Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992, 75:1092-1098.
79. Jackson JA, Waxman J, Spiekerman AM: Prostatic complications of testosterone replacement therapy. Arch Intern Med 1989, 149:2365-2366.
80. Curhan GC, Willett WC, Rimm EB, Stampfer MJ: A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. W Engl J Med 1993, 328:833-838.
81. Wasnich RD, Davis J, Ross P, Vogel J: Effect of thiazide on rates of bone mineral loss: a longitudinal study. BMJ 1990, 301:1303-1305.
82. LaCroix AZ, Wienpahl J, White LR, Wallace RB, Scherr PA, George LK, Cornoni-Huntley J, Ostfeld AM: Thiazide diuretic agents and the incidence of hip fracture. W Engl J Med 1990, 322:286-290.
83. Geusens P, Nijs J, Eben K, Jly J, Dequeker J: Cyclic etidronate and calcium in male osteoporosis [abstract]. J Bone Miner Res 1994, 9(suppl 1):397.
84. Ringe JD, Schmidt R: Low dose intermittent monofluorophosphate calcium therapy in idiopathic male osteoporosis [abstract]. Bone 1995, 16(suppl):161.
85. Johansson AG, Lindh E, Blum WF, Kollerup G, Sorensen OH, Ljunghall S: Effects of growth hormone and insulin-like growth factor 1 in men with idiopathic osteoporosis. J Clin Endocrinol Metab 1996, 81:44-48. This study analyzed the effect of growth hormone or IGF-1 therapy on biochemical markers of bone turnover in 12 patients with idiopathic osteoporosis during a period of 13 weeks (7 days of therapy and 12 weeks of washout). Both treatments increased bone formation and resorption markers.
86. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Mone C, Saccá L, Bellastella A: Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab 1993, 77:1671-1676.
87. Degerblad M, Elgindy N, Hall K, Sjöberg HE, Thorén M: Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol 1992, 126:387-393.
88. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Golberg AF,Schlenker RA, Cohn L, Rudman I, Mattson DE: Effects of human growth hormone in men over 60 years old. N Engl J Med 1990, 323:1-5.
89. Luengo M, Pons F, Martànez de Osaba MJ, Picado C: Prevention of further bone mass loss by nasal calcitonin In patients on long term glucocorticoid therapy for asthma: a two year follow up study. Thorax 1994, 49:1099-1102.
90. Struys A, Snelder AA, Mulder H: Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. Am J Med 1995, 99:235-242.
91. Reid IR, King AR, Alexander CJ, Ibbertson HK: Prevention of steroid-Induced osteoporosis with (3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD). Lancet 1988, i:143-146.
92. Greenwald M, Brandli D, Spector S, Silverman S, Golde G: Corticosteroid-induced osteoporosis: effects of treatment with slow-release sodium fluoride. Osfeoporosis Int 1992, 2:303-304.
93. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Stat M, Pocock N, Eisman J: Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993, 328:1747-1752.
94. Orwoll ES, Oviatt SK, McClung MR, Deftos LJ, Sexton G: The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med 1990, 112:29-34.
95. Khaw KT, Scragg R, Murphy S: Single-dose cholecalciferol suppresses the winter increase in parathyroid hormone concentrations in healthy older men and women: a randomized trial. Am J Clin Nutr 1994, 59:1040-1044.
96. Holbrook TL, Barrett-Connor E, Wingard D: Dietary calcium and risk of hip fracture: 14-year prospective population study. Lancet 1988, 337:1046-1049.